Palifosfamide (ZIO-201) is a proprietary stabilized metabolite of ifosfamide. Ifosfamide has been shown to be effective in high doses in treating testicular cancer, sarcoma and lymphoma.
Investigated for use/treatment in cancer/tumors (unspecified), lymphoma (unspecified), and sarcoma.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.